Production (Stage)
Avenue Therapeutics, Inc.
ATXI
$0.2088
-$0.0113-5.13%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.16M | -11.65M | -9.47M | -5.87M | -7.18M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.79M | 2.45M | -580.00K | -1.92M | -29.00K |
| Change in Net Operating Assets | 286.00K | 179.00K | -538.00K | -800.00K | -3.79M |
| Cash from Operations | -7.09M | -9.03M | -10.59M | -8.59M | -11.00M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | -1.00M | -3.00M |
| Cash from Investing | -- | -- | 0.00 | -1.00M | -3.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.17M | 11.04M | 14.16M | 14.14M | 9.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -765.00K | -1.21M | -1.14M | -1.21M | -442.00K |
| Cash from Financing | 7.40M | 9.84M | 13.02M | 12.93M | 8.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 308.00K | 811.00K | 2.44M | 3.35M | -5.04M |